Scientists at Great Ormond Street Hospital (GOSH) and University College London (UCL) have achieved what many thought was still years away: creating the first lab-grown oesophagus that can be transplanted into a living animal and fully restore the ability to swallow.
Published in the journal Nature Biotechnology, the research demonstrates the complete process — from stripping a donor organ to its bare scaffold, repopulating it with the recipient's own cells, and implanting it in a growing animal — all without the need for immunosuppression drugs. It's the first time the entire pipeline has been completed with such success.
How It Works
The process begins with a donor pig's oesophagus, which is remarkably similar in structure to a human one. Through a technique called decellularisation, scientists carefully remove all the donor's cells while preserving the underlying support structure — essentially creating a tube-shaped scaffold.
Next comes the remarkable part. Muscle cells are harvested from the recipient animal via a small biopsy, multiplied in the lab, and then injected into the scaffold. The graft is placed in a bioreactor — a specialized container that pumps vital growth fluids through the tissue for one week. During this time, the cells settle, spread, and adapt to their new home.
The entire process takes about two months from start to finish — a timeline that's compatible with current standard treatment schedules for the children who would benefit most.
Why It Matters
Around 180 babies are born with oesophageal atresia in the UK each year. Approximately 10% of these have what's called long-gap oesophageal atresia (LGOA) — a condition where the upper and lower segments of the oesophagus are separated by a gap too wide to close with simple surgery.
These babies cannot survive without intervention, but current surgical options are complex and invasive. One approach involves repositioning the stomach or intestine to bridge the gap — major operations with significant short- and long-term complications, including breathing problems, gastrointestinal issues, and an unknown long-term cancer risk.
A lab-grown replacement built from the child's own cells could eliminate many of these complications while providing a functioning food pipe that grows with the child.
Impressive Results
All eight animals that received the lab-grown oesophagus survived the critical first 30 days after transplant. By the six-month mark, the grafts had developed functional muscle, nerves, and blood vessels. The transplanted oesophagus could contract and move food naturally — just like a native food pipe.
The animals ate normally and grew at healthy rates. While some developed narrowing at the transplant sites, these were successfully managed through endoscopy — a routine procedure that mirrors standard human clinical practice.
Crucially, because the implants were built using the recipients' own cells, no immunosuppression was needed. The tissue integrated fully within three months and continued growing with the animals.
The Road to Human Trials
Dr. Marco Pellegrini, senior researcher at the UCL Great Ormond Street Institute of Child Health, said the technology "could allow us to build a child a new oesophagus, using their own cells, collected in a surgery they are having anyway, combined with a ready-prepared scaffold from pig tissue."
The research was funded by Great Ormond Street Hospital Charity, the Oak Foundation, LifeArc, and the Francis Crick Institute. While human clinical trials are still ahead, the research team has now mapped the genes within the implant structure for the first time — providing a detailed blueprint for translating this technology to human treatment.
For families of children born with severe oesophageal conditions, this breakthrough represents something profound: the realistic possibility that one day, their child could receive a personalized, lab-grown organ that functions naturally, grows with them, and doesn't require a lifetime of immunosuppressive medication.
